Evolution of intracerebral hemorrhage after intravenous tPA: Reversal of harmful effects with mast cell stabilization

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 1, 2014, Pages 176-181

  Marinkovic, Ivan ^a,b   Mattila, Olli S ^c   Strbian, Daniel ^a,b   Meretoja, Atte ^a,d   Shekhar, Shashank ^a,b   Saksi, Jani ^c   Abo Ramadan, Usama ^a,b   Rantanen, Ville ^c   Lindsberg, Perttu J ^a,c   Tatlisumak, Turgut ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Experimental MRI Laboratory   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

collagenase injection; ICH; mast cells; rat; thrombolysis; tPA

Indexed keywords

COLLAGENASE; CROMOGLYCATE DISODIUM; GELATINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BASEMENT MEMBRANE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; ENZYME ACTIVITY; FOLLOW UP; HEMISPHERE; IMMUNOHISTOCHEMISTRY; MAST CELL; MORTALITY; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; ZYMOGRAPHY;

EID: 84891830187     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.189     Document Type: Article

References (31)

1. Lees KR, Bluhmki E, Kummer von R, Brott TG, Toni D, Grotta JC et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703.
2. Runchey S, McGee S. Does this patient have a hemorrhagic stroke?: clinical findings distinguishing hemorrhagic stroke from ischemic stroke. JAMA 2010; 303: 2280-2286.
3. Foerch C, Niessner M, Back T, Bauerle M, De Marchis GM, Ferbert A et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem 2012; 58: 237-245.
4. Foerch C, Rosidi NL, Schlunk F, Lauer A, Cianchetti FA, Mandeville E et al. Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice. PLoS ONE 2013; 8: e54203.
5. Lindsberg PJ, Strbian D, Karjalainen-Lindsberg M-L. Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab 2010; 30: 689-702.
6. Strbian D, Karjalainen-Lindsberg M-L, Kovanen PT, Tatlisumak T, Lindsberg PJ. Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation 2007; 116: 411-418.
7. Strbian D, Tatlisumak T, Ramadan UA, Lindsberg PJ. Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 2007; 27: 795-802.
8. MacLellan CL, Silasi G, Poon CC, Edmundson CL, Buist R, Peeling J et al. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab 2008; 28: 516-525.
9. Gerriets T, Stolz E, Walberer M, Mü ller C, Kluge A, Bachmann A et al. Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 2004; 35: 566-571.
10. Marinkovic I, Strbian D, Pedrono E, Vekovischeva OY, Shekhar S, Durukan A et al. Decompressive craniectomy for intracerebral hemorrhage. Neurosurgery 2009; 65: 780-786.
11. Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 1997; 8: 711-713.
12. Mattila OS, Strbian D, Saksi J, Pikkarainen TO, Rantanen V, Tatlisumak T et al. Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation. Stroke 2011; 42: 3600-3605.
13. Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, Aittomäki V et al. Large-scale data integration framework provides a comprehensive view on glio-blastoma multiforme. Genome Med 2010; 2: 65.
14. Weber JE, Ebinger M, Rozanski M, Waldschmidt C, Wendt M, Winter B et al. Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study. Neurology 2013; 80: 163-168.
15. Strbian D, Karjalainen-Lindsberg M-L, Tatlisumak T, Lindsberg PJ. Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J Cereb Blood Flow Metab 2006; 26: 605-612.
16. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke 1999; 30: 1167-1173.
17. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1-5.
18. Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 1995; 45: 649-658.
19. Eisenberg PR, Sherman LA, Tiefenbrunn AJ, Ludbrook PA, Sobel BE, Jaffe AS. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation. Thromb Haemost 1987; 57: 35-40.
20. Montagne A, Hébert M, Jullienne A, Lesept F, Le Béhot A, Louessard M et al. Memantine improves safety of thrombolysis for stroke. Stroke 2012; 43: 2774-2781.
21. Pfeilschifter W, Kashefiolasl S, Lauer A, Steinmetz H, Foerch C. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator. Neuroscience 2013; 250: 181-188.
22. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006; 5: 53-63.
23. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE et al. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke 1996; 27: 490-497.
24. Xi G, Wagner KR, Keep RF, Hua Y, de Courten-Myers GM, Broderick JP et al. Role of blood clot formation on early edema development after experimental intra-cerebral hemorrhage. Stroke 1998; 29: 2580-2586.
25. Lee KR, Kawai N, Kim S, Sagher O, Hoff JT. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 1997; 86: 272-278.
26. Yang GY, Betz AL, Chenevert TL, Brunberg JA, Hoff JT. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg 1994; 81: 93-102.
27. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Spinola A, Cattaneo M et al. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1995; 25: 203-209.
28. Francis CW, Markham RE, Barlow GH, Florack TM, Dobrzynski DM, Marder VJ. Thrombin activity of fibrin thrombi and soluble plasmic derivatives. J Lab Clin Med 1983; 102: 220-230.
29. Tsuji K, Aoki T, Tejima E, Arai K, Lee S-R, Atochin DN et al. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 2005; 36: 1954-1959.
30. Wang X, Lee S-R, Arai K, Lee S-R, Tsuji K, Rebeck GW et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 2003; 9: 1313-1317.
31. Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 2008; 14: 731-737.